Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
## Scripps Just Activated the 'Poison Pill' Defense—Here's What That Means
The E.W. Scripps Company (SSP) board just dropped a shareholder rights plan after getting hit with an unsolicited acquisition bid. Sounds boring, but this is basically the nuclear option for fending off hostile takeovers.
**Here's the play:**
Scripps will hand out one special voting right per share to shareholders starting Dec 8, 2025. These rights stay dormant until someone tries to snag 10% or more of the company. Once that happens? Things get spicy.
Anyone holding these rights can buy additional Scripps shares at a 50% discount to market price. Translation: the acquirer's stake gets massively diluted, making the whole deal way more expensive. It's a financial boobytrap.
**The real move:** This gives the board breathing room to shop around for better offers or convince shareholders the current bid is trash. The rights expire in exactly one year, so this is a temporary flex—not permanent poison.
The board can nuke the whole thing anytime for just $0.001 per right if they work out a sweeter deal. Classic boardroom defense playbook.